Slowdown in French health spending in November
This article was originally published in Clinica
French health expenditure rose just 0.3% in November to Fr 36,331 million ($7,414 million) compared with the previous month. Spending for the 12 months to the end of November was Fr 389,589 million. Reimbursement for diagnostic tests remained flat, compared with a slight fall of 0.2% in October. Expenditure on auxiliary procedures, which includes EEGs and ECGs, rose 0.3% in November after an increase of 0.6% in October.
You may also be interested in...
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.